Higher doses of ACE inhibitors in black patients. Relevant in COVID-19?
philipmcmillan.substack.com
In preparing the case for autoimmunity as a cause of COVID-19, I have to look at all aspects of the disease to formulate an umbrella theory. Part of this needs to explain the apparent higher risk of mortality in black and ethnic minority communities.
Higher doses of ACE inhibitors in black patients. Relevant in COVID-19?
Higher doses of ACE inhibitors in black…
Higher doses of ACE inhibitors in black patients. Relevant in COVID-19?
In preparing the case for autoimmunity as a cause of COVID-19, I have to look at all aspects of the disease to formulate an umbrella theory. Part of this needs to explain the apparent higher risk of mortality in black and ethnic minority communities.